B. M. Klein

发表

The role of Campylobacter jejuni cytolethal distending toxin in gastroenteritis: toxin detection, antibody production, and clinical outcome

M. AbuOun, N. Boisen, K. Krogfelt, 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Levamisole Inhibits Angiogenesis in vitro and Tumor Growth in vivo

J. Rygaard, G. Houen, T. Friis, 2005, Angiogenesis.

Multiple bacterial species reside in chronic wounds: a longitudinal study

K. Krogfelt, B. M. Klein, J. Christensen, 2006, International wound journal.

Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001.

M. Muscat, D. Monnet, B. M. Klein, 2004, The Journal of antimicrobial chemotherapy.

Association between blastocyst morphology and outcome of single-blastocyst transfer.

S. Ziebe, K. Lundin, M. J. Cuesta, 2013, Reproductive biomedicine online.

Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles.

M. Fernández-Sánchez, A. Yuzpe, B. M. Klein, 2019, Reproductive biomedicine online.

Long‐term desmopressin response in primary nocturnal enuresis: open‐label, multinational study

P. Eggert, J. Nørgaard, H. Lottmann, 2009, International journal of clinical practice.

Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia.

J. Nørgaard, J. Weiss, B. M. Klein, 2011, The Journal of urology.

No need for biopsies: comparison of three sample techniques for wound microbiota determination

K. Krogfelt, B. M. Klein, M. E. Skindersoe, 2012, International wound journal.

Gender difference in antidiuretic response to desmopressin.

J. Nørgaard, B. M. Klein, L. Erichsen, 2011, American journal of physiology. Renal physiology.

The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin

A. La Marca, B. M. Klein, J. Arce, 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.

S. Nelson, B. M. Klein, J. Arce, 2015, Fertility and sterility.

antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Fertility

S. Nelson, B. M. Klein, 2015 .

The value of anti-Müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments

E. Anckaert, J. Schiettecatte, J. Smitz, 2012, Human reproduction.

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

P. De Sutter, B. Fauser, M. Fernández-Sánchez, 2014, Fertility and sterility.

Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double‐blind, placebo‐controlled trial

J. Nørgaard, N. Zinner, J. Weiss, 2012, Neurourology and urodynamics.

Luteal phase progesterone and oestradiol after ovarian stimulation: relation to response and prediction of pregnancy.

A. Andersen, B. M. Klein, J. Arce, 2018, Reproductive biomedicine online.

A randomized, double-blind, placebo-controlled, multi-center, phase 2 trial to investigate the effect of barusiban on implantation in IVF/ICSI patients

E. Bosch, B. M. Klein, J. Arce, 2019, Fertility and Sterility.

Follicular and endocrine dose responses according to anti‐Müllerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049)

P. Sutter, A. Nyboe Andersen, M. Fernández-Sánchez, 2015, Clinical endocrinology.

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.

B. Fauser, S. Nelson, A. Nyboe Andersen, 2017, Fertility and sterility.

Potential high responders and their clinical outcome following individualised FSH dosing based on AMH and body weight

E. Papaleo, K. Kozioł, B. M. Klein, 2021 .

Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight.

E. Papaleo, K. Kozioł, B. M. Klein, 2021, Reproductive biomedicine online.

Long‐term durability of the response to desmopressin in female and male nocturia patients

J. Nørgaard, B. M. Klein, K. Juul, 2013, Neurourology and urodynamics.

In Vitro Biofilm Formation of Commensal and Pathogenic Escherichia coli Strains: Impact of Environmental and Genetic Factors

S. Molin, K. Krogfelt, B. M. Klein, 2006, Journal of bacteriology.

Development and validation of an ATP method for rapid estimation of viable units in lyophilised BCG Danish 1331 vaccine.

S. E. Jensen, K. Hasløv, B. M. Klein, 2008, Biologicals : journal of the International Association of Biological Standardization.

Treatment of nocturia increases QoL

F. Daneshgari, B. M. Klein, T. Holm-Larsen, 2010 .

1528 FAST-DISSOLVING DESMOPRESSIN (MELT) IS WELL TOLERATED IN NOCTURIA: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED STUDY

J. Weiss, B. M. Klein, L. Belkoff, 2010 .

POSTER VIEWING SESSION - FEMALE (IN) FERTILITY

S. Campbell, H. Steiner, B. Mol, 2011 .

Randomized, assessor-blind, antimüllerian hormone-stratiﬁed, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta.

O. Ishihara, B. M. Klein, J. Arce, 2020, Fertility and sterility.

Surveillance of ambulance dispatch data as a tool for early warning.

K. Mølbak, E. Heegaard, B. M. Klein, 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial.

E. Bosch, B. M. Klein, J. Havelock, 2019, Reproductive biomedicine online.